Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block in IBD Patients Undergoing Major Abdominal Surgery
NCT06230003Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Quality of Recovery total score at 72 hours. Started Jul 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06230003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06230003.